Investors 1
| Date | Name | Website |
| - | Cenova Cap... | cenova.com |
Mentions in press and media 2
| Date | Title | Description |
| 08.04.2022 | Ensem Therapeutics Raises $67M in Series A Financing | Ensem Therapeutics, a Boston, MA-based biotechnology company, raised $67M in Series A funding. The round was led by GGV Capital, with participation from Pavilion Capital, Cenova Capital, Mitsui & Co. Global Investment, and CBC Group. Th... |
| 07.04.2022 | ENSEM Therapeutics, a CBC Group-Incubated Biopharma Company, Raises $67 Million in Series A Financing to Develop Small Molecule Medicines for Difficult-to-Drug Targets | BOSTON, April 7, 2022 /PRNewswire/ -- ENSEM Therapeutics Inc. (ENSEM), a Boston-based biotechnology company focusing on high value and difficult-to-drug oncology targets, announced today the closing of a series A2 financing. Incubated by CB... |